Titre :
  • Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.
Auteur : Burzykowski, T. ; Buyse, Marc ; Piccart-Gebhart, Martine ; Sledge, G. ; Carmichael, J. ; Luck, H. J. ; Mackey, John R ; Nabholtz, J.M. ; Paridaens, Robert ; Biganzoli, Laura ; Jassem, J. ; Bontenbal, M ; Bonneterre, J ; Chan, S ; Basaran, Gul ; Therasse, P.
Informations sur la publication : Journal of clinical oncology, 26, 12, (page 1987-1992)
Statut de publication : Publié, 2008-04
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Anthracyclines -- administration & dosage
Anthracyclines -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Biological Markers
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Disease-Free Survival
Female
Humans
Neoplasm Metastasis
Proportional Hazards Models
Randomized Controlled Trials as Topic -- methods
Reproducibility of Results
Survival Rate
Taxoids -- administration & dosage
Taxoids -- therapeutic use
Treatment Outcome
Note : Journal Article
Meta-Analysis
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2007.10.8407
info:pii/26/12/1987
info:pmid/18421050